FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 359:749-750 August 14, 2008 Number 7 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Perspective Roundtable Perspective by Bernat, J. L. Perspective by Veatch, R. M. Perspective by Truog, R. D. Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Boucek, M. M. PubMed Citation

For children born with inoperable congenital heart disease or advanced cardiomyopathy, cardiac transplantation is the only therapeutic option. Each year in the United States, approximately 400 heart-transplantation procedures are performed in children and adolescents. In about two thirds, the indication is complex congenital heart disease, and in the remainder it is cardiomyopathy. During the past decade, the procedure has proved lifesaving for thousands of children.

Of the 400 pediatric heart transplantations performed annually, about 100 are in infants under the age of 1 year. The 15-year survival rate among these infants is greater than 50%, increasing to 80% among those . . . [Full Text of this Article]

This article has been cited by other articles:

• Chrispin, E, Conlon Vaswani, N, English, V, Harrison, C, Sheather, J, Sommerville, A (2008). Ethics briefings. J. Med. Ethics 34: 829-830 [Full Text]